Gilead Sciences Inc. on Thursday cut one of its profit forecasts and reported first-quarter profit that missed expectations, with weaker demand for its COVID-19 drug weighing on results.
The company reported first-quarter net income of $985 million, or 80 cents a share, compared with $12 million, or two cents a share, in the same quarter last year. Revenue fell 4% to $6.35 billion, compared with $6.59 billion in the prior-year quarter.
Adjusted…
Corning declares $0.28 dividend Source link
Samsung Electronics Co.’s KR:005930 first-quarter net profit slid 86% from a year earlier, with its semiconductor segment posting a large...
Assa Abloy GAAP EPS of SEK3.32, revenue of SEK32.93B Source link
Shares of Enphase Energy Inc. dropped more than 16% in the extended session Tuesday after the energy technology company reported...
